CVE-2019-7286A memory corruption issue was addressed with improved input validation.
Updated under an hour ago ()
Does this affect you?
It affects Apple iOS and 3 other products. Add what you run to find out whether that includes you.
CISA lists it as known exploited since May 23, 2022; federal agencies had to remediate by Jun 13, 2022. Treat that date as your deadline.
Do this next
Free account, 1 product
A memory corruption issue was addressed with improved input validation. This issue is fixed in iOS 12.1.4, macOS Mojave 10.14.3 Supplemental Update. An application may be able to gain elevated privileges.
- CVSS
- 7.8 HIGH (v3.1, CISA ADP)CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
- Weakness (CWE)
- CWE-787
- Known exploited
- Added to CISA KEV May 23, 2022; federal remediation due Jun 13, 2022Apply updates per vendor instructions.
- EPSS (exploitation in the next 30 days)
- 15.94% (percentile 97)
- Assigned by
- apple
- NVD analysis
- Analyzed
- Record last updated
- Oct 21, 2025
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
Apple iOS apple:ios (from the name) | from unspecified before iOS 12.1.4 | CNA record |
Apple macOS apple:macos (from the name) | from unspecified before macOS Mojave 10.14.3 Supplemental Update | CNA record |
apple iphone_os apple:iphone_os | before 12.1.4 | NVD |
apple mac_os_x apple:mac_os_x | before 10.14.3 | NVD |
References
- https://support.apple.com/HT209601x-refsource-misc, vendor-advisory
- https://support.apple.com/HT209602x-refsource-misc, vendor-advisory
- https://support.apple.com/HT209520x-refsource-misc, vendor-advisory
- https://support.apple.com/HT209521x-refsource-misc, vendor-advisory
- https://www.cisa.gov/known-exploited-vulnerabilities-catalog?field_cve=CVE-2019-7286us-government-resource
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.